INVENTOR PHARMA products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi pharmaceutical manufacturer with a dedicated production facility and branded-generic portfolio.
INVENTOR PHARMA products in Pakistan
INVENTOR PHARMA PVT LTD has 76 medicine presentations registered in Pakistan under 37 brands, covering 30 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and Pain & musculoskeletal. Its brands with the most registered strengths and packs are VENTZON (Ceftriaxone), PARAPALS (Paracetamol), INTEK (Cefotaxime) and INVENZOL (Omeprazole). 76 products have an official DRAP price on MedInfoBase. See all 37 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Inventor Pharma (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- B-128, Sindhi Muslim Cooperative Housing Society, Karachi 75210, Pakistan · 75210
- Website
- inventorpharma.pk ↗
- Phone
- 021-36410075
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where INVENTOR PHARMA PVT LTD is priced against the market
69 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| INCIP | Ciprofloxacin | 200 mg/100 mL | IV infusion | 100ML | 088363 | PKR 161.29 | PKR 1.61/mL | 🔒 Pharma Pro |
| INMEX | Moxifloxacin | 400 MG | Tablet | 5'S | 110360 | PKR 721.19 | PKR 144.24/tablet | 🔒 Pharma Pro |
| LEVOIN | Levofloxacin | 500 mg | Tablet | 10’S | 086489 | PKR 670.95 | PKR 67.10/tablet | 🔒 Pharma Pro |
| LEVOIN | Levofloxacin | 250 mg | Tablet | 10’S | 086490 | PKR 403.22 | PKR 40.32/tablet | 🔒 Pharma Pro |
| VORCIN | Ciprofloxacin | 250 mg | Tablet | 10’S | 086491 | PKR 209.68 | PKR 20.97/tablet | 🔒 Pharma Pro |
| VORCIN | Ciprofloxacin | 500 mg | Tablet | 10’S | 086492 | PKR 346.77 | PKR 34.68/tablet | 🔒 Pharma Pro |
| VORCIN | Ciprofloxacin | 750 mg | Tablet | 10’S | 086493 | PKR 370.97 | PKR 37.10/tablet | 🔒 Pharma Pro |
All 37 INVENTOR PHARMA brands in Pakistan
- AZIN Azithromycin · 250 mg capsule
- AZITHKAR Azithromycin · 250 mg tablet, 500 mg tablet
- FERRAX FP Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet, 100 mg + 0.35 mg/5 mL syrup
- IN-D3 Cholecalciferol · 5 mg/mL injection
- INART 20 Artemether + Lumefantrine · 20 mg + 120 mg tablet
- INART A Artemether · 80 mg/mL injection
- INART DS Artemether + Lumefantrine · 40 mg + 240 mg tablet
- INART FORTE 80 Artemether + Lumefantrine · 80 mg + 480 mg tablet
- INCIP Ciprofloxacin · 200 mg/100 mL infusion
- INDEON Ondansetron · 8 mg tablet, 8 mg/4 mL injection
- INGLEE Metronidazole · 500 MG/100 mL infusion
- INKET Ketamine · 500 mg/10 mL injection
- INLAXIN Cephalexin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- INMEX Moxifloxacin · 400 MG tablet
- INTEK Cefotaxime · 1 G injection, 250 MG injection, 500 MG injection
- INTEROZ Letrozole · 2.5 mg tablet
- INVENFEN Ibuprofen · 100 mg/5 mL suspension
- INVENZOL Omeprazole · 20 MG capsule, 40 mg capsule
- INXIME Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 400 mg capsule
- INXIME DRY Cefixime · 200 mg/5 mL suspension
- INZEDIM Ceftazidime · 1 G injection, 250 MG injection, 500 MG injection
- LEDENZO-LID Linezolid · 400 mg tablet
- LEVOIN Levofloxacin · 250 mg tablet, 500 mg tablet
- LIDOCAINE Lidocaine · 1 % injection, 2 % injection
- MENFO-MET Metformin · 250 mg tablet
- MENFO-METTABLET Metformin · 1 G tablet
- PARAPALS Paracetamol · 120 mg/5 mL suspension, 250 mg/5 mL suspension
- PARAPALS 100MG/ML Paracetamol · 100 mg/mL drops
- RITHCLAR Clarithromycin · 250 mg tablet, 500 mg tablet
- Tazo-In Piperacillin + tazobactam · 2 g + 2.25 g injection, 4 g + 0.5 g injection
- TRANZA INJECION Tranexamic acid · 500 MG/5 mL injection
- VENOXY Doxycycline · 100 mg capsule
- VENTZON Ceftriaxone · 1000 MG injection, 250 MG injection, 500 MG injection
- VORCIN Ciprofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Water for Injection Water for Injection · 5 mL injection
- Xotrz Itraconazole · 100 mg capsule
- ZOB Fluconazole · 150 MG capsule
INVENTOR PHARMA: common questions
How many products does INVENTOR PHARMA have in Pakistan?
INVENTOR PHARMA PVT LTD has 76 registered medicine presentations in Pakistan, sold under 37 brands and covering 30 generic medicines.
What are the main brands of INVENTOR PHARMA?
By number of registered strengths and packs, its largest brands are VENTZON (Ceftriaxone), PARAPALS (Paracetamol), INTEK (Cefotaxime), INVENZOL (Omeprazole) and FERRAX FP (Iron polymaltose complex + Folic acid). This is not a sales ranking.
Which therapy areas does INVENTOR PHARMA cover?
The most products are in Anti-infectives (44), Gastrointestinal & hepatology (7), Pain & musculoskeletal (7), Endocrine & metabolic (6) and Vitamins, minerals & nutrition (5).
Where can I see INVENTOR PHARMA medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.